Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Chicago, IL
NPI: 1164481412Primary Practice Location
ADVOCATE ILLINOIS MASONIC MEDICAL CENTER
836 W Wellington Ave, Chicago, IL
Primary Employer
Advocate Medical Group
advocatehealth.com
HQ Phone
Get M.D. Sigrun's Phone NumberMobile
Get M.D. Sigrun's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 194 | 397 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 121 | 149 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 61 | 105 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 35 | 61 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 30 | 49 |
Authors: Brendan Curti, Kim Margolin, Gregory Daniels, Lynn Feun, Robert Andtbacka
Journal: J Immunother Cancer
Authors: Nikhil Khushalani, Robert Mc Williams, Hussein Tawbi, David Mcdermott
Journal: Immunotherapy
Publication Date: 2023-11-08
Interventions to Address Sexual Problems in People With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline.
Authors: Shari Damast, David Kushner
Publication Date: 2017-12-12
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, OTHER: Data Collection
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Nivolumab, BIOLOGICAL: Ipilimumab
Lead Sponsor: Wake Forest University Health Sciences
Intervention / Treatment: OTHER: Screening
